• high bioavailability and absorption of active ingredients
• eco-friendly glass packaging
• high content of active ingredients in the daily dose
• registered trademark Levagen®

Supplements the diet with palmitic acid monoethanolamide (PEA) with increased bioavailability.

LipiSperse® technology increases the bioavailability and absorption of active ingredients (CWD-Cold Water Dispersion).

_____________________________________________________________________________________

Composition in a daily dose  (1 capsule)

Palmitic acid monoethanolamide (PEA) /Levagen®+/         350 mg

_____________________________________________________________________________________

Ingredients:  palmitic acid monoethanolamide (PEA); LipiSperse® technology (emulsifier: fatty acid esters and polyglycerol; solvent: fractionated coconut oil; emulsifiers: mono- and diglycerides of fatty acids, sunflower lecithin; antioxidant: vitamin E acetate); anti-caking agent: silicon dioxide; capsule: hydroxypropylmethylcellulose.

Levagen®+ is a registered trademark of Gencor Pacific Ltd.

LipiSperse® is a registered trademark of Pharmako Biotechnologies Pty Ltd.

How to use:  1 capsule a day. Store in a closed container at room temperature, out of the reach of small children.

Notes: Do not exceed the recommended daily dose. Dietary supplements cannot be used as a substitute for a varied diet. Do not use in case of hypersensitivity to any ingredient of the preparation. The preparation should not be used by pregnant or breastfeeding women and children and adolescents under 18 years of age.